Parte, Capitolo, Paragrafo
1 I, 1,1(3) | Baboon-to-human cardiac xenotransplantation in a neonate, Jama, 1985,
2 I, 1,1(5) | Starzl T.E. Baboon liver xenotransplantation In: Cooper DKC, Kemp E,
3 I, 1,1(6) | after baboon-to-human liver xenotransplantation. J Virol. 2001; 75:2825-
4 I, 1,1(7) | Cooper D.K.C. Clinical xenotransplantation – A brief review of the
5 I, 1,1(8) | Cfr. Allan j.f. Xenotransplantation at a crossroad: prevention
6 I, 1,1(10) | kidney xenograft model, Xenotransplantation 2000, 7:186-96; Cozzi E.,
7 I, 1,1(10) | the study of discordant xenotransplantation, Transplantation 2001; 7:
8 I, 1,1(11) | Murase N., et al., Will xenotransplantation ever be feasible?, J Am
9 I, 2,2(16) | plasmapheresis/immunoadsorption, Xenotransplantation 1995, 2:253-63. ~
10 I, 2,2(17) | rejection following discordant xenotransplantation in a nonhuman primate model,
11 I, 2,2(17) | vivo model of pit-to-human xenotransplantation, Transplantation 1995, 60:
12 I, 2,2(19) | the study of discordant xenotransplantation, Transplantation 2001; 7:
13 I, 2,2(22) | Acute vascular rejection, Xenotransplantation 1998, 5:169-175. ~
14 I, 2,2(24) | Cfr. Bach F.H., Xenotransplantation: problems and prospects,
15 I, 2,2(27) | of vascular responses in xenotransplantation: inflammation and apoptosis,
16 I, 2,4(39) | transmission in pig-to-human xenotransplantation, Xenotransplantation 2000;
17 I, 2,4(39) | pig-to-human xenotransplantation, Xenotransplantation 2000; 7:143-155. ~
18 I, 2,4(40) | production Specification for xenotransplantation, Ann NY Acad Sc 1998, 862:
19 I, 3,6(47) | Holgersson J., Widner H., Xenotransplantation for CNS repair: immunological
20 I, 3,6(49) | et al., Report of the xenotransplantation advisory committee of the
21 I, 3,6(49) | transplantation. The present status of xenotransplantation and its potential role in
22 II, 2,12(65)| Medical Progress. The case of Xenotransplantation, Hastings Center Report
23 II, 2,12(65)| Transplants: the Ethics of Xenotransplantation, London: Nuffield Council
24 II, 2,12(65)| Xenograft Transplantation, Xenotransplantation: Science, Ethics, and Public
25 II, 2,12(65)| et al., Uncertainty in Xenotransplantation: Individual Benefit versus
26 II, 2,12(65)| Piggy Went to Market: The Xenotransplantation and Xenozoonose Debate,
27 II, 2,12(65)| issues concerning the use of Xenotransplantation products in humans: guidance
28 II, 2,13(67)| Alwayn I.P., Cooper D.K., Xenotransplantation: The Challenge to Current
29 II, 2,14(68)| Vedi Beckmann J.P., Xenotransplantation aus ethischer Sicht. Eine
30 II, 2,14(68)| Starting Clinical Trials of Xenotransplantation. Reflections on the Ethics
31 II, 2,14(69)| Quine S. et Al., Aversion to Xenotransplantation, Nature, 1995, 378 :434 ;
32 II, 2,16(71)| infectious disease risks in xenotransplantation, Med Health Care Philos
33 II, 2,17(72)| Vedi Kress J.M., Xenotransplantation: ethics and economics, Food
34 II, 2,17(72)| economic and legal aspects of xenotransplantation, Law Hum Genome Rev 2000
35 II, 3,21(75)| the Swedish Committee on Xenotransplantation, the Spanish Xenotransplantation
36 II, 3,21(75)| Xenotransplantation, the Spanish Xenotransplantation Sub-committee, the Argentine
37 II, 3,21(75)| Argentine National Commission on Xenotransplantation, the US Department of Health
38 II, 3,21(75)| Human Services Committee on Xenotransplantation, the United Kingdom Xenotransplantation
39 II, 3,21(75)| Xenotransplantation, the United Kingdom Xenotransplantation Interim Regulatory Authority,
40 II, 3,21(75)| Authority, and the Italian Xenotransplantation Commission. In France, the
41 II, 3,21(75)| to prepare guidelines on xenotransplantation. In Canada 'Health Canada'
42 II, 3,21(75)| the authority to regulate xenotransplantation as a new technology.
|